About this Device
SURGIFLO Hemostatic Matrix, mixed with sterile saline or thrombin solution, is indicated in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or other conventional methods is ineffective or impractical. This flowable gelatin matrix can be prepared inside or outside the sterile field and can be used in laparoscopic surgery to control oozing and prevent bleeding.
Economic Outcomes
SURGIFLO was associated with reduced cost and resource utilization compared with FLOSEAL Matrix.A3
• Significantly shorter OR TimeB,C4
• Shorter mean length of stay (LOS)D3
• 5% lower ICU admissionsE3
Clinical Outcomes
A systematic review and meta-analysis of 6 clinical studies with over 39,000 patients demonstrated efficacy, safety, and efficiency across the following endpoints:2
• Blood transfusions
• Minor / Major complications
• Surgical / Operating time
Features & Benefits
Stops Bleeding Fast
SURGIFLO stays in place even during active bleeding,F5,6 so you can count on it to deliver fast hemostasis right where you need it.

Save Time, Flow Faster
With over 2 minutes faster prep time than FLOSEAL, you can rely on SURGIFLO without interrupting the flow of procedure.G7-9
Maintain Uniform Viscosity
SURGIFLO maintains a uniform consistency and viscosity from beginning to end, so you can rely on a steady flow as you go.H10
Device Specifications and Comparisons
Device Specifications and Comparisons
SURGIFLO Hemostatic Matrix, mixed with thrombin solution, is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or other conventional methods is ineffective or impractical.
Select Competitive Products: Baxter FLOSEAL Hemostatic Matrix
Featured Product |
||
---|---|---|
![]() |
![]() |
|
SURGIFLO™ Hemostatic Matrix |
Not Applicable |
|
Codes |
2994, 2991, MS1995
|
—
|
Description |
Flowable gelatin matrix with thrombin (2994), Flowable gelatin matrix (2991), Delivery device for minimally invasive procedures (MS1995) |
— |
Indication |
SURGIFLO Hemostatic Matrix, mixed with thrombin solution, is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or other conventional methods is ineffective or impractical. (2991) SURGIFLO Hemostatic Matrix, mixed with sterile saline or thrombin solution, is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or other conventional methods is ineffective or impractical. (MS1995) The SURGIFLO Endoscopic Applicator is intended for use in delivering hemostatic agents to bleeding surgical sites through a 5 mm trocar or larger. (MS1995) |
— |
Size |
|
— |
Hemostatic Agent & Accessory |
|
— |
Absorption Time |
4-6 Weeks |
— |
Storage Requirements |
|
— |
Preparation Time |
|
— |
Shelf Life |
2 Years |
— |
Material/Composition |
|
— |
Mechanism of Action |
SURGIFLO Hemostatic Matrix with thrombin provides a matrix for platelet adherence, accelerating the formation of the platelet plug and aids in fibrin clot formation (2994) SURGIFLO Hemostatic Matrix without thrombin provides a matrix for platelet adherence, accelerating the formation of the platelet plug (2991) |
— |
NDC/Distributor Code |
|
— |
Qty./Box |
6 |
— |
Supporting Documentation
Evidence Resources
Product Resources
© Ethicon US, LLC. 2022.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.